[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100290286":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":27,"centralContacts":24,"locations":32,"responsibleParty":46,"collaborators":24,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":24,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":24,"enrollmentInfo":57,"targetDuration":24,"studyType":60,"phases":61,"briefSummary":52,"conditions":63,"keywords":24,"overallStatus":65,"whyStopped":24,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Bausch Health Americas, Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"IDP-124 Lotion","EXPERIMENTAL","IDP-124 Lotion, twice-daily application",[13],"Drug: IDP-124 Lotion",{"label":15,"type":16,"description":17,"interventionNames":18},"IDP-124 Vehicle Lotion","ACTIVE_COMPARATOR","IDP-124 Vehicle Lotion, twice-daily application",[19],"Drug: IDP-124 Vehicle Lotion",[21,25],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG",[9],null,{"type":22,"name":15,"description":17,"armGroupLabels":26,"otherNames":24},[15],[28],{"name":29,"affiliation":30,"role":31},"Anya Loncaric","Valeant Pharmaceitucals","STUDY_DIRECTOR",[33],{"facility":34,"status":24,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":24},"Valeant Site 05","Fremont","California","94536","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-121.98857,37.54827,{"lat":44,"lon":43},{"type":47,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100290286","phase-3-efficacy-and-safety-of-idp-124-lotion-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-in-pediatric-and-adult-subjects-100290286",true,"NCT03058783","Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects","A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects","Inclusion Criteria:\n\n* Male or female at least 2 years of age and older\n* Written and verbal informed consent must be obtained; subjects less than age of consent must sign an assent for the study and a parent or a legal guardian must sign the informed consent (if subject reaches age of consent during the study they should be re-consented at the next study visit)\n* Nonimmunocompromized male or female who failed to respond adequately to other topical prescription treatment for AD or for whom those treatments are not advisable\n* Subjects must be willing to comply with study instructions and return to the clinic for required visits; subjects under the age of consent must be accompanied by the parent or legal guardian at the time of assent\u002Fconsent signing\n\nExclusion Criteria:\n\n* Females who are pregnant, breast feeding, or who wish to become pregnant during the study period\n* Active cutaneous bacterial or viral infection in any treatment area at Baseline (eg, clinically infected AD)\n* Sunburn, extensive scarring, or pigmented lesion(s) in any treatment area at Baseline, which would interfere with evaluations\n* History of confounding skin conditions, eg, psoriasis, rosacea, erythroderma, or ichthyosis (other than ichthyosis vulgaris)\n* History or presence of:\n* basal cell carcinoma of skin effectively treated more than 2 years ago\n* carcinoma of cervix effectively treated more than 5 years ago\n* immunological deficiencies or diseases, HIV, or serious recurrent infection\n* clinically significant severe renal insufficiency or severe hepatic disorders\n* Current or recent serious infection","ALL","2 Years",{"count":58,"type":59},328,"ACTUAL","INTERVENTIONAL",[62],"PHASE3",[64],"Atopic Dermatitis","COMPLETED","2023-04-12",{"date":68,"type":59},"2023-05-08",{"date":70,"type":59},"2018-08-14",{"date":72,"type":59},"2020-05-12",{"name":5,"class":6},1]